Medicine guide
Procomvax
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Haemophilus B conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine
- Made by
- Sanofi Pasteur MSD, SNC
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- PROCOMVAX is indicated for vaccination against invasive disease caused by Haemophilus influenzae type b and against infection caused by all known subtypes of hepatitis B virus in infants 6 weeks to 15 months of age.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Sanofi Pasteur MSD, SNC |
|---|---|
| Active substance | Haemophilus B conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07CA · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 1999-05-07 |
| Last updated by the regulator | 2009-07-29 |
| EMA product number | EMEA/H/C/000231 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).